Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1994
Enhanced antitumor efficacy in mice by combination treatment with interleukin-1 alpha and interferon-alpha
M J Brunda, R B Wright, L Luistro, et al.
The Journal of Experimental Medicine
|
September 1, 1992
Interleukin 1: an important mediator of host resistance against Pneumocystis carinii
W Chen, E A Havell, L L Moldawer, et al.
The Journal of Clinical Investigation
|
June 1, 1985
Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis
N L Letvin, D C Linch, G P Beardsley, et al.
Peptides
|
July 1, 1992
Synthesis and biological activity of novel C-terminal-extended and biotinylated growth hormone-releasing factor (GRF) analogs
R M Campbell, Y Lee, T F Mowles, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 20, 1998
IL-1 receptor accessory protein is an essential component of the IL-1 receptor
E B Cullinan, L Kwee, P Nunes, et al.
Antisense Research and Development
|
January 1, 1993
A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kappa B p65 causes sequence-specific immune stimulation
K W McIntyre, K Lombard-Gillooly, J R Perez, et al.
The Journal of Biological Chemistry
|
September 22, 1995
Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity
S A Greenfeder, T Varnell, G Powers, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1997
Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice
M Labow, D Shuster, M Zetterstrom, et al.
European Journal of Immunology
|
December 1, 1996
Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice
K W McIntyre, D J Shuster, K M Gillooly, et al.
The Journal of Experimental Medicine
|
April 1, 1991
Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody
K W McIntyre, G J Stepan, K D Kolinsky, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1994
Enhanced antitumor efficacy in mice by combination treatment with interleukin-1 alpha and interferon-alpha
M J Brunda, R B Wright, L Luistro, et al.
The Journal of Experimental Medicine
|
September 1, 1992
Interleukin 1: an important mediator of host resistance against Pneumocystis carinii
W Chen, E A Havell, L L Moldawer, et al.
The Journal of Clinical Investigation
|
June 1, 1985
Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis
N L Letvin, D C Linch, G P Beardsley, et al.
Peptides
|
July 1, 1992
Synthesis and biological activity of novel C-terminal-extended and biotinylated growth hormone-releasing factor (GRF) analogs
R M Campbell, Y Lee, T F Mowles, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 20, 1998
IL-1 receptor accessory protein is an essential component of the IL-1 receptor
E B Cullinan, L Kwee, P Nunes, et al.
Antisense Research and Development
|
January 1, 1993
A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kappa B p65 causes sequence-specific immune stimulation
K W McIntyre, K Lombard-Gillooly, J R Perez, et al.
The Journal of Biological Chemistry
|
September 22, 1995
Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity
S A Greenfeder, T Varnell, G Powers, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 1, 1997
Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice
M Labow, D Shuster, M Zetterstrom, et al.
European Journal of Immunology
|
December 1, 1996
Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice
K W McIntyre, D J Shuster, K M Gillooly, et al.
The Journal of Experimental Medicine
|
April 1, 1991
Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody
K W McIntyre, G J Stepan, K D Kolinsky, et al.
Page
of 3